Join to View Full Profile
3800 Park Nicollet BlvdSt. Louis Park, MN 55416
Phone+1 952-993-3248
Dr. Menge is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 2001 - 2004
Hennepin HealthcareResidency, Internal Medicine, 1997 - 2001- University of Minnesota Medical SchoolClass of 1997
Certifications & Licensure
MN State Medical License 2000 - 2026
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eSmartLog, HealthPort, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification SoftLab, SCC Soft Computer, 2012, 2014, 2016-2017
Publications & Presentations
PubMed
- 94 citationsNab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial.Vaibhav Sahai, Paul J. Catalano, Mark M. Zalupski, Sam J. Lubner, Mark R. Menge
JAMA Oncology. 2018-12-01 - 18 citationsUtility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapyAnne H. Blaes, Aamer Rehman, David M. Vock, Xianghua Luo, Mark Menge
Vascular Health and Risk Management. 2015-11-24
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
